Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management

被引：42
作者：
Mandala, M. [1 ]
Falanga, A. [2 ]
Roila, F. [3 ]
机构：
[1] Unit Med Oncol, Bergamo, Italy
[2] Osped Riuniti Bergamo, Dept Hematol & Oncol, Haemostasis & Thrombosis Ctr, Div Immunohaematol & Transfus Med, I-24100 Bergamo, Italy
[3] Hosp Santa Maria, Dept Med Oncol, Terni, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
MOLECULAR-WEIGHT HEPARIN; PREVENTION;
D O I：
10.1093/annonc/mdq199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：v274 / v276
页数：3
相关论文
共 10 条
[1]   Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients [J].
Carrier, M. ;
Le Gal, G. ;
Cho, R. ;
Tierney, S. ;
Rodger, M. ;
Lee, A. Y. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) :760-765
[2]  
Chew HK, 2006, ARCH INTERN MED, V166, P458
[3]   Deep vein thrombosis in cancer: the scale of the problem and approaches to management [J].
Falanga, A ;
Zacharski, L .
ANNALS OF ONCOLOGY, 2005, 16 (05) :696-701
[4]   Development and validation of a predictive model for chemotherapy-associated thrombosis [J].
Khorana, Alok A. ;
Kuderer, Nicole M. ;
Culakova, Eva ;
Lyman, Gary H. ;
Francis, Charles W. .
BLOOD, 2008, 111 (10) :4902-4907
[5]   Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].
Lee, AYY ;
Levine, MN ;
Baker, RI ;
Bowden, C ;
Kakkar, AK ;
Prins, M ;
Rickles, FR ;
Julian, JA ;
Haley, S ;
Kovacs, MJ ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153
[6]   American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer [J].
Lyman, Gary H. ;
Khorana, Alok A. ;
Falanga, Anna ;
Clarke-Pearson, Daniel ;
Flowers, Christopher ;
Jahanzeb, Mohammad ;
Kakkar, Ajay ;
Kuderer, Nicole M. ;
Levine, Mark N. ;
Liebman, Howard ;
Mendelson, David ;
Raskob, Gary ;
Somerfield, Mark R. ;
Liebman, Howard ;
Mendelson, David ;
Raskob, Gary ;
Somerfield, Mark R. ;
Thodiyil, Paul ;
Trent, David ;
Francis, Charles W. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) :5490-5505
[7]   Venous thromboembolism and cancer:: Guidelines of the Italian Association of Medical Oncology (AIOM) [J].
Mandala, M. ;
Falanga, A. ;
Piccioli, A. ;
Prandoni, P. ;
Pogliani, E. M. ;
Labianca, R. ;
Barni, S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (03) :194-204
[8]   Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study [J].
Meyer, G ;
Marjanovic, Z ;
Valcke, J ;
Lorcerie, B ;
Gruel, Y ;
Solal-Celigny, P ;
Le Maignan, C ;
Extra, JM ;
Cottu, P ;
Farge, D .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) :1729-1735
[9]   Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients A Meta-analysis [J].
Nalluri, Shobha Rani ;
Chu, David ;
Keresztes, Roger ;
Zhu, Xiaolei ;
Wu, Shenhong .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (19) :2277-2285
[10]   Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis [J].
Prandoni, P ;
Lensing, AWA ;
Piccioli, A ;
Bernardi, E ;
Simioni, P ;
Girolami, B ;
Marchiori, A ;
Sabbion, P ;
Prins, MH ;
Noventa, F ;
Girolami, A .
BLOOD, 2002, 100 (10) :3484-3488
1